NFKB1 and viral infectious disease: Pre-treatment of HBECs with caffeic acid phenethyl ester (CAPE), a specific inhibitor of NF-κB, resulted in the inhibition of viral infection-induced p65 phosphorylation at 1 hpi (Supplementary Fig. 3b).